Parmiani G - Search Results

1

Growth of human melanoma xenografts is suppressed by systemic angiostatin gene therapy.

Rodolfo M, Catò EM, Soldati S, Ceruti R, Asioli M, Scanziani E, Vezzoni P, Parmiani G, Sacco MG. Rodolfo M, et al. Among authors: parmiani g. Cancer Gene Ther. 2001 Jul;8(7):491-6. doi: 10.1038/sj.cgt.7700331. Cancer Gene Ther. 2001. PMID: 11498770

2

Immunological gene therapy with ex vivo gene-modified tumor cells: a critique and a reappraisal.

Parmiani G, Rodolfo M, Melani C. Parmiani G, et al. Hum Gene Ther. 2000 Jun 10;11(9):1269-75. doi: 10.1089/10430340050032375. Hum Gene Ther. 2000. PMID: 10890737 Review.

3

An autologous T cell clone overcomes intra-melanoma heterogeneity for susceptibility to cell-mediated lysis by using multiple lytic mechanisms: in vitro and in vivo analysis.

Mazzocchi A, Rodolfo M, Parmiani G, Anichini A. Mazzocchi A, et al. Among authors: parmiani g. Melanoma Res. 1991 Aug-Sep;1(3):169-76. Melanoma Res. 1991. PMID: 1841713

4

Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells.

Vagliani M, Rodolfo M, Cavallo F, Parenza M, Melani C, Parmiani G, Forni G, Colombo MP. Vagliani M, et al. Among authors: parmiani g. Cancer Res. 1996 Feb 1;56(3):467-70. Cancer Res. 1996. PMID: 8564954

5

Cytotoxic T lymphocyte response against non-immunoselected tumor antigens predicts the outcome of gene therapy with IL-12-transduced tumor cell vaccine.

Rodolfo M, Zilocchi C, Cappetti B, Parmiani G, Melani C, Colombo MP. Rodolfo M, et al. Among authors: parmiani g. Gene Ther. 1999 May;6(5):865-72. doi: 10.1038/sj.gt.3300874. Gene Ther. 1999. PMID: 10505112

6

Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen.

Rodolfo M, Luksch R, Stockert E, Chen YT, Collini P, Ranzani T, Lombardo C, Dalerba P, Rivoltini L, Arienti F, Fossati-Bellani F, Old LJ, Parmiani G, Castelli C. Rodolfo M, et al. Among authors: parmiani g. Cancer Res. 2003 Oct 15;63(20):6948-55. Cancer Res. 2003. PMID: 14583496

7

A merging duo in melanoma formation.

Rodolfo M, Pierotti MA, Parmiani G. Rodolfo M, et al. Among authors: parmiani g. J Invest Dermatol. 2005 Dec;125(6):xii-xiii. doi: 10.1111/j.0022-202X.2005.23965.x. J Invest Dermatol. 2005. PMID: 16354173 Free article. No abstract available.

8

Detection of mutated BRAFV600E variant in circulating DNA of stage III-IV melanoma patients.

Daniotti M, Vallacchi V, Rivoltini L, Patuzzo R, Santinami M, Arienti F, Cutolo G, Pierotti MA, Parmiani G, Rodolfo M. Daniotti M, et al. Among authors: parmiani g. Int J Cancer. 2007 Jun 1;120(11):2439-44. doi: 10.1002/ijc.22598. Int J Cancer. 2007. PMID: 17315191

9

Role of T cells and tumour necrosis factor in antitumour activity and toxicity of flavone acetic acid.

Pratesi G, Rodolfo M, Rovetta G, Parmiani G. Pratesi G, et al. Among authors: parmiani g. Eur J Cancer. 1990;26(10):1079-83. doi: 10.1016/0277-5379(90)90056-y. Eur J Cancer. 1990. PMID: 2148884

10

Adoptive immunotherapy of a mouse colon carcinoma with recombinant interleukin-2 alone or combined with lymphokine-activated killer cells or tumor-immune lymphocytes. Survival benefit of adjuvant post-surgical treatments and comparison with experimental metastases model.

Rodolfo M, Salvi C, Bassi C, Parmiani G. Rodolfo M, et al. Among authors: parmiani g. Cancer Immunol Immunother. 1990;31(1):28-36. doi: 10.1007/BF01742492. Cancer Immunol Immunother. 1990. PMID: 2306753 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

434 results

Search Page

Filters